Read articles from Global

May 26, 2026 by substack.com

Research on third-hand exposure from vaping is adding new complexity to debates about nicotine product risk, toxicology, and public health communication. While animal models can provide useful insight into possible biological effects, researchers caution that findings must be interpreted carefully when assessing real-world human exposure. The debate highlights the importance of distinguishing between potential hazards observed under experimental conditions and actual population-level risk compared with cigarette smoke. It also reinforces the need for proportionate scientific communication that recognises uncertainty without obscuring the substantial risk differences between combustible and non-combustible nicotine products.

May 25, 2026 by weareinnovation.global

"The Household Case for Innovation" survey by We Are Innovation interviews friends and family of ex-smokers in five countries, highlighting positive impacts of Innovative Nicotine Products (INPs) on cessation. Results show reduced secondhand smoke exposure and improved social interactions and health habits post-quitting, with strong support for INP access. Findings emphasize the influence of witnessing successful INP use on perceptions and advocate for including broader perspectives in tobacco control debates. Support for INP access correlates with personal experiences, challenging policymakers to consider a wider range of stakeholders. Experience-driven advocacy underscores the importance of involving affected communities in shaping tobacco control policies.

May 25, 2026 by vapingpost.com

Growing divisions within the global nicotine debate are becoming increasingly visible through competing public health narratives surrounding World Vape Day and World No Tobacco Day. While both movements ultimately focus on reducing smoking-related disease and mortality, major disagreements remain over the role of vaping and other reduced-risk nicotine products in achieving that goal. Harm reduction advocates argue that non-combustible alternatives can accelerate declines in cigarette smoking, whereas opponents continue to emphasise concerns related to youth uptake, nicotine dependence, and long-term uncertainty. The debate reflects broader tensions between abstinence-focused tobacco control strategies and approaches centred on relative risk, consumer behaviour, and evidence-based harm reduction.

May 25, 2026 by disobedientmargins.com

Criticism of global tobacco control policy is increasingly focusing on the way smoking continues to shape public health thinking around nicotine. Researchers and harm reduction advocates argue that many regulatory frameworks still approach all nicotine products through the historical lens of combustible cigarettes, despite major differences in toxicological risk. The discussion highlights concerns that outdated assumptions about nicotine may be influencing public perception, media narratives, and policy decisions surrounding reduced-risk alternatives. Questions are increasingly being raised over whether public health institutions are adapting quickly enough to scientific evidence and evolving patterns of nicotine use.

May 22, 2026 by substack.com

Stigma surrounding nicotine use and smoking continues to be recognised as an important barrier to smoking cessation and harm reduction. Researchers and public health commentators increasingly argue that shame-based messaging may discourage smokers from seeking support, switching to lower-risk alternatives, or engaging openly with healthcare systems. The discussion highlights growing concern that moralised narratives around nicotine can oversimplify addiction while reducing the effectiveness of public health communication. Questions remain over whether future tobacco control strategies can better balance prevention goals with approaches grounded in empathy, behavioural science, and evidence-based harm reduction.

May 22, 2026 by substack.com

Debates surrounding vaping policy are increasingly framed as a conflict between protecting youth and supporting tobacco harm reduction for adult smokers. Critics argue that presenting these objectives as mutually exclusive oversimplifies a far more complex public health challenge. Researchers and policy analysts continue to emphasise that reducing youth nicotine uptake and expanding access to lower-risk alternatives for smokers do not necessarily require opposing regulatory approaches. The discussion reflects broader tensions around risk communication, nicotine perception, and whether public health policy can simultaneously prioritize prevention, harm reduction, and evidence-based regulation.

May 22, 2026 by cannaspecialists.org

Comparisons between the health risks of alcohol and cannabis continue to play a growing role in debates surrounding drug policy and harm reduction. Researchers generally agree that both substances carry potential health risks, though the patterns of harm, dependence, toxicity, and social impact differ significantly between them. Evidence increasingly suggests that alcohol contributes substantially more to mortality, chronic disease, overdose risk, and violence at the population level, while concerns surrounding cannabis tend to focus more on cognitive effects, mental health, and long-term heavy use. The discussion highlights broader questions about how public health policy communicates relative risk and whether current regulatory frameworks consistently reflect scientific evidence across different psychoactive substances.

May 22, 2026 by cannaspecialists.org

Comparisons between the health risks of alcohol and cannabis continue to play a growing role in debates surrounding drug policy and harm reduction. Researchers generally agree that both substances carry potential health risks, though the patterns of harm, dependence, toxicity, and social impact differ significantly between them. Evidence increasingly suggests that alcohol contributes substantially more to mortality, chronic disease, overdose risk, and violence at the population level, while concerns surrounding cannabis tend to focus more on cognitive effects, mental health, and long-term heavy use. The discussion highlights broader questions about how public health policy communicates relative risk and whether current regulatory frameworks consistently reflect scientific evidence across different psychoactive substances.

May 22, 2026 by cannaspecialists.org

Comparisons between the health risks of alcohol and cannabis continue to play a growing role in debates surrounding drug policy and harm reduction. Researchers generally agree that both substances carry potential health risks, though the patterns of harm, dependence, toxicity, and social impact differ significantly between them. Evidence increasingly suggests that alcohol contributes substantially more to mortality, chronic disease, overdose risk, and violence at the population level, while concerns surrounding cannabis tend to focus more on cognitive effects, mental health, and long-term heavy use. The discussion highlights broader questions about how public health policy communicates relative risk and whether current regulatory frameworks consistently reflect scientific evidence across different psychoactive substances.

May 22, 2026 by clearingtheair.eu

Growing evidence suggests that taxation policies targeting vaping products may influence smoking behaviour in unintended ways. Researchers and public health analysts warn that higher taxes on non-combustible nicotine alternatives can reduce their price advantage over cigarettes, potentially discouraging smokers from switching away from combustible tobacco. The debate highlights the importance of considering relative risk when designing fiscal and regulatory approaches to nicotine products. Questions are increasingly being raised over whether taxation frameworks aimed at reducing nicotine use overall may inadvertently slow progress in reducing smoking-related disease and mortality.